Financials

  • Market Capitalization 39.11 B
  • Employee 883
  • Founded 2014
  • CEO N/A
  • Website www.revmed.com
  • Headquarter Delaware, United States
  • FIGI BBG00829F4P8
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-13.39
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
238
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
663.09 USD-0.22%-0.01%+8.11%+15.81%69.52 B USD
295
ARGX
argenx SE - American Depositary Shares
876.25 USD-0.16%-5.71%-1.84%+54.53%54.23 B USD
386
ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
288.06 USD-3.58%-8.97%+1.82%-9.10%38.46 B USD
498
MRNA
Moderna, Inc. - Common Stock
67.01 USD-1.85%-18.43%+30.42%+101.90%26.59 B USD

Nouvelles